4P-Pharma will attend the upcoming ALS Drug Development 2022 starting next week, May 24-26 in Boston (US).
Célia Rabhi, our PhD student working on our 4P019 project on neurodegenerative diseases, will attend it.
To learn more about us, please feel free to connect with us.
For further information on the event, click here.
